Cargando…

Relative Ratios Enhance the Diagnostic Power of Phospholipids in Distinguishing Benign and Cancerous Ovarian Masses

Ovarian cancer remains a highly lethal disease due to its late clinical presentation and lack of reliable early biomarkers. Protein-based diagnostic markers have presented limitations in identifying ovarian cancer. We tested the potential of phospholipids as markers of ovarian cancer by utilizing in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yagi, Tsukasa, Kuschner, Cyrus E., Shoaib, Muhammad, Choudhary, Rishabh C., Becker, Lance B., Lee, Annette T., Kim, Junhwan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7016589/ https://www.ncbi.nlm.nih.gov/pubmed/31888002 http://dx.doi.org/10.3390/cancers12010072

Ejemplares similares

Challenges and Inconsistencies in Using Lysophosphatidic Acid as a Biomarker for Ovarian Cancer
por: Yagi, Tsukasa, et al.
Publicado: (2019)

Plasma metabolomics supports the use of long-duration cardiac arrest rodent model to study human disease by demonstrating similar metabolic alterations
por: Shoaib, Muhammad, et al.
Publicado: (2020)

Mitochondrial transplantation therapy for ischemia reperfusion injury: a systematic review of animal and human studies
por: Hayashida, Kei, et al.
Publicado: (2021)

Increased plasma disequilibrium between pro- and anti-oxidants during the early phase resuscitation after cardiac arrest is associated with increased levels of oxidative stress end-products
por: Shoaib, Muhammad, et al.
Publicado: (2021)

Exogenous mitochondrial transplantation improves survival and neurological outcomes after resuscitation from cardiac arrest
por: Hayashida, Kei, et al.
Publicado: (2023)

Diagnostic accuracy of inflammatory markers for distinguishing malignant and benign ovarian masses
por: Eo, Wan Kyu, et al.
Publicado: (2018)

Utility of Preoperative Inflammatory Markers to Distinguish Epithelial Ovarian Cancer from Benign Ovarian Masses
por: Li, Lian, et al.
Publicado: (2021)

Recent advances in personalizing cardiac arrest resuscitation
por: Kuschner, Cyrus E., et al.
Publicado: (2019)

Distinguishing benign from malignant adrenal masses
por: Francis, Isaac R.
Publicado: (2015)

Combination of cardiac and thoracic pump theories in rodent cardiopulmonary resuscitation: a new method of three-side chest compression
por: Okuma, Yu, et al.
Publicado: (2019)

Pharmacological Approach for Neuroprotection After Cardiac Arrest—A Narrative Review of Current Therapies and Future Neuroprotective Cocktail
por: Choudhary, Rishabh C., et al.
Publicado: (2021)

Threshold adjusted vagus nerve stimulation after asphyxial cardiac arrest results in neuroprotection and improved survival
por: Choudhary, Rishabh C., et al.
Publicado: (2022)

Comparison of glutaminase and cancer antigen 125 for distinguishing benign and malignant ovarian tumors
por: Winarno, Gatot Nyarumenteng Adhipurnawan, et al.
Publicado: (2023)

Prospective analysis of SARS-CoV-2 dissemination to environmental surfaces during endoscopic procedures
por: Somerville, Carter C., et al.
Publicado: (2021)

Identification of unusual phospholipids from bovine heart mitochondria by HPLC-MS/MS
por: Kim, Junhwan, et al.
Publicado: (2020)

Distinguishing between metastatic and benign adrenal masses in patients with extra-adrenal malignancies
por: Chen, Jinchao, et al.
Publicado: (2022)

The diagnostic utility of diffusion weighted MRI imaging and ADC ratio to distinguish benign from malignant renal masses: sorting the kittens from the tigers
por: de Silva, Suresh, et al.
Publicado: (2021)

Sonoelastography in Distinguishing Benign from Malignant Complex Breast Mass and Making the Decision to Biopsy
por: Kim, Mi Young, et al.
Publicado: (2013)

An Ultrasonic-Based Radiomics Nomogram for Distinguishing Between Benign and Malignant Solid Renal Masses
por: Li, Chunxiang, et al.
Publicado: (2022)

A Novel Classifier Based on Urinary Proteomics for Distinguishing Between Benign and Malignant Ovarian Tumors
por: Ni, Maowei, et al.
Publicado: (2021)

Using Genomic Variation to Distinguish Ovarian High-Grade Serous Carcinoma from Benign Fallopian Tubes
por: Gonzalez-Bosquet, Jesus, et al.
Publicado: (2022)

Serum microRNA profiling to distinguish papillary thyroid cancer from benign thyroid masses
por: Graham, M. Elise R., et al.
Publicado: (2015)

Corrigendum: An ultrasonic-based radiomics nomogram for distinguishing between benign and malignant solid renal masses
por: Li, Chunxiang, et al.
Publicado: (2023)

Distinguishing benign from malignant liver tumours
por: Heiken, Jay P.
Publicado: (2007)

Transcriptome analysis identifies putative multi-gene signature distinguishing benign and malignant pancreatic head mass
por: Chhatriya, Bishnupriya, et al.
Publicado: (2020)

Efficacy of IOTA simple rules, O-RADS, and CA125 to distinguish benign and malignant adnexal masses
por: Xie, Wen ting, et al.
Publicado: (2022)

Adrenal wash-out CT: moderate diagnostic value in distinguishing benign from malignant adrenal masses
por: Schloetelburg, Wiebke, et al.
Publicado: (2021)

Coexistence of Benign Brenner Tumor with Mucinous Cystadenoma in an Ovarian Mass
por: Nazari, Farzaneh, et al.
Publicado: (2020)

Elastography in Distinguishing Benign from Malignant Thyroid Nodules
por: Colakoglu, Bulent, et al.
Publicado: (2016)

Distinguishing benign from malignant pelvic mass utilizing an algorithm with HE4, menopausal status, and ultrasound findings
por: Wilailak, Sarikapan, et al.
Publicado: (2015)

Tissue‐Specific Metabolic Profiles After Prolonged Cardiac Arrest Reveal Brain Metabolome Dysfunction Predominantly After Resuscitation
por: Choi, Jaewoo, et al.
Publicado: (2019)

Distinguishing benign notochordal cell tumors from vertebral chordoma
por: Yamaguchi, Takehiko, et al.
Publicado: (2008)

Liquid biopsies to distinguish malignant from benign pulmonary nodules
por: Tao, Rui, et al.
Publicado: (2021)

Cell Surface Vibrations Distinguish Malignant from Benign Cells
por: Wohl, Ishay, et al.
Publicado: (2023)

HDL Phospholipids, but Not Cholesterol Distinguish Acute Coronary Syndrome From Stable Coronary Artery Disease
por: Meikle, Peter J., et al.
Publicado: (2019)

Excessive phospholipid peroxidation distinguishes ferroptosis from other cell death modes including pyroptosis
por: Wiernicki, Bartosz, et al.
Publicado: (2020)

Alteration of plasma phospholipids distinguish schizophrenic patients from controls: A targeted metabolomics study
por: Naifar, M., et al.
Publicado: (2023)

Alteration of plasma phospholipids distinguish schizophrenic patients from controls: A targeted metabolomics study
por: Naifar, M., et al.
Publicado: (2023)

A method for measuring the molecular ratio of inhalation to exhalation and effect of inspired oxygen levels on oxygen consumption
por: Shinozaki, Koichiro, et al.
Publicado: (2021)

Simple ultrasound rules to distinguish between benign and malignant adnexal masses before surgery: prospective validation by IOTA group
por: Timmerman, Dirk, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_n7ioaepedajqljvsg6oev72ql3